*Mission*
Elsevier is committed to making genuine contributions to the science and
health communities.
Elsevier. Building Insights. Breaking Boundaries.

 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Elsevier websites
</wps/find/elsevierwebsites.cws_home/elsevierwebsites> | Alerts
</wps/find/home_content.cws_home/alertingservices>
	Elsevier 		

	Product information search 	
	Search all Elsevier sites 	
Search <javascript:submitSearchForm(document.forms['searchForm'])> 	
Advanced Product Search
</wps/find/advproductsearch.cws_home?action=product_search&search=no>

	

Go to Elsevier home page </wps/find/homepage.cws_home>

	
	Products
</wps/find/subject_area_browse.cws_home/?sh1State=-null-SAR-SAA-SAC-SAD-SAF-SA1-SAI-SAJ-SAK-SAQ-SAP-SAB-SAE-SAL-SAN-SAO-SAG-SAH-SAM&sh2State=&allParents=y&showAll=y>
	

	Leukemia Research
</wps/find/journaldescription.cws_home/583/authorinstructions?navopenmenu=-2>
	

	Journal information

	Product description
</wps/find/journaldescription.cws_home/583/description#description> 	

	Editorial board
</wps/find/journaleditorialboard.cws_home/583/editorialboard#editorialboard>
	

	Audience </wps/find/journalaudience.cws_home/583/description#audience> 	

	Abstracting/indexing
</wps/find/journalabstracting.cws_home/583/abstracting#abstracting> 	

	Subscription information

	Bibliographic and ordering information
</wps/find/journalbibliographicinfo.cws_home/583/description#bibliographicinfo>
	

	Conditions of sale
</wps/find/journalconditionsofsale.cws_home/583/conditionsofsale#conditionsofsale>
	

	Dispatch dates
</wps/find/journaldispatchdates.cws_home/583/dispatchdates#dispatchdates> 	

	Journal-related information

	Impact factor
</wps/find/journalimpactfactors.cws_home/583/description#impactfactors> 	

	Most downloaded articles
<javascript:openWindow("http://top25.sciencedirect.com/?journal_id=01452126","topdownload")>
	

	Other journals in same subject area
</wps/find/products_in_subject_and_group.cws_home/583> 	

	Support & contact </wps/find/supportfaq.cws_home/overview> 	

	About Elsevier </wps/find/intro.cws_home/ataglance> 	

	Select your view
</wps/find/journaldescription.cws_home/583/authorinstructions?navopenmenu=4>
	

	

			
	
	LEUKEMIA RESEARCH	
		
	
Clinical and Laboratory Studies

*Guide for Authors*

*Submission of Articles*

*All Articles and Material* should be submitted on-line via *EES -
External link http://ees.elsevier.com/lr/ .* Please refer to the
'Tutorial for Authors' located on the EES site for guidance on the
electronic submission process. If you are unable to submit online or
have any general queries, please contact the Editorial Offices regarding
alternatives:

*Professor Terry Hamblin*
Royal Bournemouth Hospital
Castle Lane East
Bournemouth BH7 7DW
UK

Tel: +44 (0) 1202 704783
Fax: +44 (0) 1202 300248
E-mail: terjoha@aol.com <mailto:terjoha@aol.com>

or

*Dr John M. Bennett*
Medical Oncology Unit
University of Rochester Medical Center
601 Elmwood Avenue, Box 704
Rochester, NY 14642
USA

Tel: +1 585 275 4915
Fax: +1 585 442 0039
E-mail: john_Bennett@urmc.rochester.edu
<mailto:john_Bennett@urmc.rochester.edu>

*For Case of the Month*

Ellin Berman, Memorial Sloan Kettering Cancer Center, 1275 New York
Avenue, New York, NY 10021, USA

Tel: +1 212 639 7762
Fax: +1 212 794 4338

*Types of Contribution*
/Original Articles/ usually do not exceed 10 to 12 pages of text but
longer papers may be considered if relevant. Original full-length
research papers which have not been published previously, except in a
preliminary form, may be submitted as regular papers. Original articles
reporting on clinical trials must conform to the guidelines of the
Working Group on Recommendations for Reporting of Clinical Trials (Table 1).

/Reviews and Editorials/ should be submitted after prior consultation
with the Editors.

/Brief Communications and Preliminary Reports/ should not exceed 5 pages
of text, 4 illustrations and 8 references.

/Letters to LEUKEMIA RESEARCH/ should clearly indicate the purpose of
the letter by a brief striking title and should not exceed 2 pages of
typescript.

/Comments on Published Papers/ like "Letters to LEUKEMIA RESEARCH" but
also mentioning the title of the paper to which it is addressed.

/Cases of the Month/ should not exceed 5 pages of typescript.

/Congress Letters/ are free reports on one or several sessions of
Congress, Workshops or Symposia (also closed ones), signed by the
author(s) whose name appears in the List of Contents. Indicate complete
information on the meeting covered, including programme.

/Open Forum/ concerns hypotheses, models or experiments which authors
wish to see performed but cannot perform themselves. Comments made under
this heading engage only the authors and not the Journal, and
publication will be at the discretion of the Editors.

Submission of an article implies that the work described has not been
published previously (except in the form of an abstract or as part of a
published lecture or academic thesis), that it is not under
consideration for publication elsewhere, that its publication is
approved by all authors and tacitly or explicitly by the responsible
authorities where the work was carried out, and that, if accepted, it
will not be published elsewhere in the same form, in English or in any
other language, without the written consent of the Publisher.

*Role of corresponding author*
The corresponding author of a manuscript for /Leukemia Research/ has the
duty to ensure that all the named authors have seen and approved the
original and any revised version of the paper and are in agreement with
its content before it is submitted to the Editorial Office. Each author
should have participated sufficiently in the work to take public
responsibility for the content. The corresponding author should also
ensure that all those who have contributed to the research are
acknowledged appropriately either as a co-author or in the
Acknowledgements. In addition, the corresponding author has the prime
responsibility for ensuring the paper is correctly prepared according to
the Guide for Authors. Submitted manuscripts not complying with the
Guide for Authors may be returned to the authors for possible revision
and resubmission.

Upon acceptance of an article, authors will be asked to transfer
copyright (for more information on copyright see External link
http://ees.elsevier.com/lr/). This transfer will ensure the widest
possible dissemination of information. A letter will be sent to the
corresponding author confirming receipt of the manuscript. A form
facilitating transfer of copyright will be provided. If excerpts from
other copyrighted works are included, the author(s) must obtain written
permission from the copyright owners and credit the source(s) in the
article. Elsevier has preprinted forms for use by authors in these
cases: contact ELSEVIER, Global Rights Department, P.O. Box 800, Oxford,
OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail:
permissions@elsevier.com <mailto:permissions@elsevier.com>

When submitting by post, three (3) hardcopies are required. Be very
careful to follow the style for headings, references, key words and
other matters as seen in a recent issue of the journal. Please supply
FAX and E-mail addresses if available.

All manuscripts are peer-reviewed. On receipt of the first decision
letter authors should send their revised manuscript within three months
in order to ensure that the scientific content of their manuscript is
timely and up to date.

*Preparation of manuscripts*
1. The Chief Editors request that papers submitted for publication
should be written concisely and clearly. Manuscripts should be written
in English. Authors whose native language is not English are strongly
advised to have their manuscripts checked by an English-speaking
colleague prior to submission. Either the Concise Oxford Dictionary or
Webster's New International Dictionary may be used as a standard for
English spelling.

/Authors in Japan please note:/
Upon request, Elsevier Japan will provide authors with a list of people
who can check and improve the English of their paper (before
submission). Please contact our Tokyo office:
Elsevier Japan
9-15, Higashi-Azabu 1-chome
Minato-ku, Tokyo 106-0044
Japan
Tel. (+81) 3-5561-5032
Fax: (+81)3-5561-5045
E-mail: info@elsevier.co.jp <mailto:info@elsevier.co.jp>

2. Manuscripts should be organised in the following sequence:
Cover page (see above)
Abstract
Keywords
Introduction
Materials and methods
Results
Discussion (including Conclusions)
Acknowledgments and any additional information concerning research
grants, etc.
References
Tables
Figure captions

3. In typing the manuscript, titles and subtitles should not be run
within the text. They should be typed on a separate line, without
indentation. Use lower-case letter type. First and second order headings
should be numbered.

4. SI units should be used, but authors may include conversions for
unfamiliar units (1 bar=0.1 MPa). Do not include periods. Note the
following conventions: e.g. not eg., rev min^-1 not rpm, mg kg^-1 or
l^-1 not ppm, 1 bar equals 0.1 MPa, round off units to eliminate
unnecessary decimal places, e.g. 124 mu not 0.124 mm (note space between
number and unit), l not L for litre, kg not Kg, s not sec, min not mins,
h not hr, d for day, y not yr, 25 t ha^-1 not 25 tonnes/ha, 3 mg cm^-3
not three mg per cubic cm, 23?C and 23% (no spaces), (Keating et al.,
1996) not (Keating et al., 1996), al. is an abbreviation of alii (others
- Latin). Molar concentrations should appear in small caps.

5. Abbreviations may be used for unwieldy names which occur frequently
and such abbreviations must be defined the first time they occur in the
text. Conventional abbreviations, e.g. EDTA, ATP, 2,4-D should be used
in preference to freshly coined ones.

6. Elsevier reserves the privilege of returning to the author for
revision accepted manuscripts and illustrations which are not in the
proper form given in this guide. On arrival at the Editorial Office,
papers will be checked to determine if they conform to the style and
format for /Leukemia Research/. Papers that do not comply may be
returned to the corresponding author with a check list detailing faults
and omissions.

7. Avoid new or uncommon acronyms. Use single letters (Greek, Roman,
italic) for variables with subscripts as appropriate.

*Title*
This should be clear, descriptive and brief. Avoid non-specific phrases
such as "A study of..." or "The effects of...". Do not give the title a
numbered subtitle or series number.

*Abstract*
The abstract should be clear, descriptive and not longer than 100 words.

*Keywords*
Keywords are index terms or descriptions for information retrieval
systems, normally 6 to 8 items. Words selected should reflect the
essential topics of the article and may be taken from both the title and
the text.

*Introduction*
This should give the reasons for doing the work. As this is a specialist
journal a detailed review of the literature is not necessary. The
Introduction should preferably conclude with a final paragraph stating
concisely and clearly the Aims and Objectives of the investigation.

*Materials and methods*
A full technical description of a method should be given in detail only
when the method is new.

*Results*
This need only report results of representative experiments illustrated
by Tables and Figures. Use well-known statistical tests in preference to
obscure ones. Consult a statistician or a statistics text for detailed
advice.

*Discussion*
This section must not recapitulate results but should relate the
authors' experiments to other work and give their conclusions, which may
be given in a subsection headed *Conclusions.*

*Acknowledgments*
Do not include grant numbers or institutional journal publication
numbers. All papers must include an acknowledgements section that
details financial support and any conflicts of interest.

An example of an acknowledgement section follows below:

This work was supported in part by a grant-in-aid from the Ministry of
Education, Culture, Sports, Science and Technology of Japan (No.14570180).

*Tables*
1. Authors should take notice of the limitations set by the size and
lay-out of the journal. Large tables should be avoided. Reversing
columns and rows will often reduce the dimensions of a table.

2. If many data are to be presented, an attempt should be made to divide
them over two or more tables.

3. Drawn tables, from which blocks need to be made, should not be folded.

4. Tables should be numbered according to their sequence in the text.
The text should include references to all tables.

5. Each table should be typewritten on a separate page of the
manuscript. Tables should never be included in the text.

6. Tables and their footnotes should be typed using a readable uniform
font of the same size as that used in the text. Each text should have a
brief and self-explanatory title.

7. Column headings should be brief, but sufficiently explanatory.
Standard abbreviations of units of measurement should be added between
parentheses.

8. Vertical lines should not be used to separate columns. Leave some
extra space between the columns instead.

9. Any explanation essential to the understanding of the table should be
given as a footnote at the bottom of the table.

10. Zero results must be represented by 0 and no determination by ND;
the dash sign (-) is ambiguous. Report data in such a way that readers
can assess the degree of experimental variation and estimate the
variability or precision of the findings. Use the standard deviation SD
and the mean to summarise data and to show the variability among
individuals. Use the standard error of the mean SEM to show the
precision of the sample mean. Always state the number of measurements on
which means are based. In tables and figures use asterisks to indicate
probability values (P). In footnotes or text show the degree of
significance of P, e.g. P <0.05*.

*Preparation of electronic illustrations*
Submitting your artwork in an electronic format helps us to produce your
work to the best possible standards, ensuring accuracy, clarity and a
high level of detail.

• Always supply high-quality printouts of your artwork, in case
conversion of the electronic artwork is problematic.
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier,
Helvetica, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files, and supply a
separate listing of the files and the software used.
• Provide all illustrations as separate files and as hardcopy printouts
on separate sheets.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.

Files can be stored on 3? inch diskette, ZIP-disk or CD (either MS-DOS
or Macintosh).

A detailed guide on electronic artwork is available on our website:
External link http://ees.elsevier.com/lr/.

*If you are unable to submit your files in an electronic format, then
please adhere to the following instructions:*
1. All illustrations (line drawings and photographs) should be submitted
separately, unmounted and not folded. They should be camera ready.
Proportion figure and tables to fit 75-mm or 160-mm column widths.

2. Illustrations should be numbered according to their sequence in the
text. References should be made in the text to each illustration.

3. Each illustration should be identified on the reverse side (or - in
the case of line drawings - on the lower front side) by its number and
the name of the author. An indication of the top of the illustrations is
required in photographs of profiles, thin sections, and other cases
where doubt can arise.

4. Illustrations should be designed with the format of the page of the
journal in mind. Illustrations should be of such a size as to allow a
reduction of 50%.

5. Lettering should be in black ink or by printed labels. Make sure that
the size of the lettering is big enough to allow a reduction of 50%
without becoming illegible. The lettering should be in English. Use the
same kind of lettering throughout in a sans serif typeface (e.g.
Helvetica, Arial, Univers, Swiss etc.)

6. If a scale should be given, use bar scales on all illustrations
instead of numerical scales that must be changed with reduction.

7. Each illustration should have a caption. The captions to all
illustrations should be typed in sequence on a separate sheet of the
manuscript.

8. Explanations should be given in the typewritten legend. Drawn text in
the illustrations should be kept to a minimum.

9. Photographs are only acceptable if they have good contrast and
intensity. Sharp and glossy copies are required. Reproductions of
photographs already printed cannot be accepted.

*You are urged to visit this site; some excerpts from the detailed
information are given here.*

/Formats/ Regardless of the application used, when your electronic
artwork is finalised, please "save as" or convert the images to one of
the following formats (Note the resolution requirements for line
drawings, halftones, and line/halftone combinations given below.):

EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: Colour or greyscale photographs (halftones): always use a minimum
of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a
minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these
Microsoft Office applications please supply "as is".

*Please do not:*
• Supply embedded graphics in your wordprocessor (spreadsheet,
presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT,
WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.

/Colour reproduction/

Submit colour illustrations as original photographs, high-quality
computer prints or transparencies, close to the size expected in
publication, or as 35 mm slides. Polaroid colour prints are not
suitable. *If, together with your accepted article, you submit usable
colour figures then Elsevier will ensure, at no additional charge, that
these figures will appear in colour on the web (e.g., ScienceDirect and
other sites) regardless of whether or not these illustrations are
reproduced in colour in the printed version.* For colour reproduction in
print, you will receive information regarding the costs from Elsevier
after receipt of your accepted article. For further information on the
preparation of electronic artwork, please see External link
http://ees.elsevier.com/lr/.

Please note: Because of technical complications which can arise by
converting colour figures to 'grey scale' (for the printed version
should you not opt for colour in print) please submit in addition usable
black and white prints corresponding to all the colour illustrations.

*References*
All publications cited in the text should be presented in a list of
references following the text of the manuscript. In the text refer to
references by a number in square brackets on the line (e.g. Since
Peterson[1]), and the full reference should be given in a numerical list
at the end of the paper. References should be given in the following form:
1. Latagliata R, Concetta Petti M, Mandelli F. Acute myeloid leukemia in
the elderly: 'per aspera ad astra'? Leukemia Res 1999;23:603-613.
2. Alfrey V. The isolation of subcellular components. In: Brachet J,
Mirsky AE, editors. The cell, biochemistry, physiology, morphology I.
New York: Academic Press, 1959. p. 200.

*Note: Authors are strongly encouraged to check the accuracy of each
reference against its original source.*

In the case of publications in any language other than English, the
original title is to be retained. However, the titles of publications in
non-Roman alphabets should be transliterated, and a notation such as
"(in Russian)" or "(in Greek, with English abstract)" should be added.

Work accepted for publication but not yet published should be referred
to as "in press". Authors should provide evidence (such as a copy of the
letter of acceptance).

References concerning unpublished data, theses, and "personal
communications" should not be cited in the reference list but may be
mentioned in the text.

*Formulae*
1. Formulae should be typewritten, if possible. Leave ample space around
the formulae.

2. Subscripts and superscripts should be clear.

3. Greek letters and other non-Roman or handwritten symbols should be
explained in the margin where they are first used. Take special care to
show clearly the difference between zero (0) and the letter O, and
between one (1) and the letter l.

4. Give the meaning of all symbols immediately after the equation in
which they are first used.

5. For simple fractions use the solidus (/) instead of a horizontal line.

6. Equations should be numbered serially at the right-hand side in
parentheses. In general only equations explicitly referred to in the
text need be numbered.

7. The use of fractional powers instead of root signs is recommended.
Also powers of e are often more conveniently denoted by exp.

8. Levels of statistical significance which can be mentioned without
further explanation are *P <0.05, * *P <0.01 and * * *P <0.001.

9. In chemical formulae, valence of ions should be given as, e.g., Ca^2+
, not as Ca^++ .

10. Isotope numbers should precede the symbols, e.g., ^18 O.

*Footnotes*
Footnotes should only be used to provide addresses of authors or to
provide explanations essential to the understanding of Tables.

/Supplementary data/

Elsevier now accepts electronic supplementary material to support and
enhance your scientific research. Supplementary files offer the author
additional possibilities to publish supporting applications, movies,
animation sequences, high-resolution images, background datasets, sound
clips and more. Supplementary files supplied will be published online
alongside the electronic version of your article in Elsevier web
products, including ScienceDirect: External link
http://www.sciencedirect.com. In order to ensure that your submitted
material is directly usable, please ensure that data is provided in one
of our recommended file formats. Authors should submit the material in
electronic format together with the article and supply a concise and
descriptive caption for each file. For more detailed instructions please
visit: External link http://ees.elsevier.com/lr/.

*Enquiries*
Authors can keep a track on the progress of their accepted article, and
set up e-mail alerts informing them of changes to their manuscript's
status, by using the "Track a Paper" feature at:External link
http://www.elsevier.com/trackarticle. For privacy, information on each
article is password-protected. The author should key in the "Our
Reference" code (which is in the letter of acknowledgement sent by the
publisher on receipt of the accepted article) and the name of the
corresponding author. In case of problems or questions, authors may
contact the Author Service Department, E-mail:
authorsupport@elsevier.com <mailto:authorsupport@elsevier.com>.

*Proofs*
When your manuscript is received at the Publisher it is considered to be
in its final form. Proofs are not to be regarded as 'drafts'.

One set of page proofs in PDF format will be sent by e-mail to the
corresponding author, to be checked for typesetting/editing. No changes
in, or additions to, the accepted (and subsequently edited) manuscript
will be allowed at this stage. Proofreading is solely your responsibility.

A form with queries from the copy editor may accompany your proofs.
Please answer all queries and make any corrections or additions required.

The Publisher reserves the right to proceed with publication if
corrections are not communicated. Return corrections within two working
days of receipt of the proofs. Should there be no corrections, please
confirm this.

Elsevier will do everything possible to get your article corrected and
published as quickly and accurately as possible. In order to do this we
need your help. When you receive the (PDF) proof of your article for
correction, it is important to ensure that all of your corrections are
sent back to us in one communication. Subsequent corrections will not be
possible, so please ensure your first sending is complete. Note that
this does not mean you have any less time to make your corrections, just
that only one set of corrections will be accepted.

*Offprints*
1. Twenty-five offprints for regular papers will be supplied free of charge.
2. Additional offprints can be ordered on an offprint order form, which
is included with the proofs.
3. UNESCO coupons are acceptable in payment of extra offprints.

	
		

		

		
	
Printer-friendly version <javascript:openPrinterFriendlyPage()>
  Printer-friendly version <javascript:openPrinterFriendlyPage()>

	

		

		
	
	
 Home </wps/find/homepage.cws_home> | Site map
</wps/find/sitemap.cws_home/sitemap> | Privacy policy
</wps/find/privacypolicy.cws_home/privacypolicy> | Terms and Conditions
</wps/find/termsconditions.cws_home/termsconditions> | Feedback
</wps/find/feedbackform.cws_home> | A Reed Elsevier
<http://www.reed-elsevier.com> company 	
 Copyright © 2007 Elsevier B.V. </wps/find/homepage.cws_home> All rights
reserved.

	

